Log in to save to my catalogue

Sage Therapeutics: U.S. FDA Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington'...

Sage Therapeutics: U.S. FDA Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington'...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2882599148

Sage Therapeutics: U.S. FDA Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington's Disease

About this item

Full title

Sage Therapeutics: U.S. FDA Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington's Disease

Publisher

Jacksonville: Close-Up Media, Inc

Journal title

Health & Beauty Close - Up, 2023

Language

English

Publication information

Publisher

Jacksonville: Close-Up Media, Inc

More information

Alternative Titles

Full title

Sage Therapeutics: U.S. FDA Grants SAGE-718 Orphan Drug Designation for the Treatment of Huntington's Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_2882599148

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2882599148

How to access this item